Fig. 3From: Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entitiesResults of the meta-analysis and prognostic data of IMT, FET::CREB-fused. Results of the meta-analysis including 72 IMT, FET::CREB-fused. Kaplan–Meier estimates of overall survival (OS) and event free survival (PFS). The median OS is not reached. The median EFS is 11 months. IMT intracranial mesenchymal tumorBack to article page